Generated by AI
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small- and large-molecule therapies for immuno-inflammatory diseases. The company centers its work on conditions with significant unmet medical need, using its proprietary KINect drug discovery platform and integrated research capabilities to advance product candidates through early development. Aclaris Therapeutics’ portfolio includes therapeutics aimed at inflammatory and autoimmune disorders, with programs spanning dermatology-related conditions and other immune-mediated diseases. In addition to its core therapeutics business, the company operates a contract research segment through Confluence Discovery Technologies, which provides laboratory and drug discovery services to pharmaceutical and biotechnology partners. Based in Wayne, Pennsylvania, Aclaris Therapeutics plays a specialized role in the biopharmaceutical market by combining internal drug development with research services for external collaborators.
Website701 Lee Road
Wayne, PA, 19087
United States
The latest articles about ACRS.
Tipranks Press Release.
Summary of Nov 16's posts. Generated by AI.
Summary of Jun 26's posts. Generated by AI.
Summary of Oct 22's posts. Generated by AI.
Summary of Jun 26's posts. Generated by AI.
Investors talking about ACRS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.